Morgan Stanley Rapt Therapeutics, Inc. Call Options Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RAPT
# of Institutions
17Shares Held
7.02MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.44MShares$26.6 Million0.0% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$17.4 Million52.54% of portfolio
-
Column Group LLC San Francisco, CA1.33MShares$14.5 Million16.17% of portfolio
-
Kpcb Xv Associates, LLC649KShares$7.07 Million43.54% of portfolio
-
Ponoi Ii Management, LLC San Francisco, CA145KShares$1.58 Million9.14% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $323M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...